Navigation Links
Over-use of antibiotics in fish-for-food industry encourages bacterial resistance and disease

The heavy use of antibiotics in the rearing of fish could be detrimental to the health of the fish, but also that of animals and humans, a recent report says. This practice encourages bacterial resistance and could lead to the evolution of resistant strains of bacteria in animals and humans as well as the fish themselves. A more judicious approach to the use of prophylactic (preventative) antibiotics is necessary.

Dr Felipe Cabello and his colleagues at New York Medical College, reported these findings in the July issue of 'Environmental Microbiology'. It is common practice in the fish industry, particularly in developing countries, to use large amounts of antibiotics to prevent infection. The antibiotics used are often non-biodegradable and remain in the aquaculture environment for long periods of time. This encourages the growth of bacteria which can survive in the presence of antibiotics - antibiotic resistant bacteria.

Eventually this process could lead to increased antibiotic resistance in the 'disease-causing' bacteria (pathogens) of fish. The properties which make bacteria resistant can also be transferred to human and animal pathogens, leading to increased infectious disease in fish, animals and humans alike.

When antibiotics are mixed with fish food, residual antibiotics may be found in fish products and fish meat. People who eat these products will be inadvertently consuming antibiotics, leading to changes in their normal microbial environment, or 'microflora' and making them more susceptible to bacterial infection.

"If we don't curb the heavy use of prophylactic antibiotics in aquaculture, then we will ultimately see more and more antibiotic resistant pathogens emerging, causing increased disease to fish, animals and humans alike" said Dr Cabello.

A global effort to curb the over-use of antibiotics in the rearing of finfish is essential in preventing these detrimental effects to fish, animal and human health.


'"/>

Source:Blackwell Publishing Ltd.


Related biology news :

1. Research on antibiotics receives historical recognition
2. Unusual antibiotics show promise against deadly superbugs
3. Doctors should stop prescribing antibiotics for the common cold, review advises
4. Researchers find how some antibiotics kill bacteria
5. Einstein researchers identify new way that bacteria develop resistance to antibiotics
6. Study findings offer potential new targets for antibiotics
7. New class of antibiotics effective against drug-resistant bacteria discovered in fungi
8. Children overprescribed antibiotics for sore throat
9. Creation of antibiotic in test tube holds promise for better antibiotics
10. Protein clue to tailor-made antibiotics
11. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... World Technology Awards. uBiome is one of just six company finalists in the ... In addition to uBiome, companies nominated as finalists in this year’s awards include ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/7/2016)... San Diego (PRWEB) , ... December 07, 2016 ... ... safety data from its phase I/II dose escalation and expansion clinical trial for ... 2016 in Vienna, Austria. The purpose of the trial was to determine the ...
Breaking Biology Technology: